291 related articles for article (PubMed ID: 14601352)
1. A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
Lenox-Smith AJ; Reynolds A
Br J Gen Pract; 2003 Oct; 53(495):772-7. PubMed ID: 14601352
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
4. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
[TBL] [Abstract][Full Text] [Related]
7. A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.
Hackett D; Haudiquet V; Salinas E
Eur Psychiatry; 2003 Jun; 18(4):182-7. PubMed ID: 12814852
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
9. Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
Nimatoudis I; Zissis NP; Kogeorgos J; Theodoropoulou S; Vidalis A; Kaprinis G
Int Clin Psychopharmacol; 2004 Nov; 19(6):331-6. PubMed ID: 15486518
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
11. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
Stahl SM; Entsuah R; Rudolph RL
Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
[TBL] [Abstract][Full Text] [Related]
15. Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.
Boyer P; Mahé V; Hackett D
Eur Psychiatry; 2004 Aug; 19(5):272-9. PubMed ID: 15276659
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.
Lyndon GJ; Prieto R; Wajsbrot DB; Allgulander C; Bandelow B
Int Clin Psychopharmacol; 2019 May; 34(3):110-118. PubMed ID: 30870236
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
Feighner JP; Entsuah AR; McPherson MK
J Affect Disord; 1998 Jan; 47(1-3):55-62. PubMed ID: 9476744
[TBL] [Abstract][Full Text] [Related]
19. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Meoni P; Salinas E; Brault Y; Hackett D
J Clin Psychiatry; 2001 Nov; 62(11):888-93. PubMed ID: 11775049
[TBL] [Abstract][Full Text] [Related]
20. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
Entsuah AR; Huang H; Thase ME
J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
